Expression of interleukin-12 is increased in psoriatic skin

被引:191
作者
Yawalkar, N [1 ]
Karlen, S
Hunger, R
Brand, CU
Braathen, LR
机构
[1] Univ Bern, Inselspital, Inst Immunol & Allergol, CH-3010 Bern, Switzerland
[2] Univ Bern, Inselspital, Dermatol Clin, CH-3010 Bern, Switzerland
关键词
interleukin-12; psoriasis; nRT-PCR-immunohistochemistry;
D O I
10.1046/j.1523-1747.1998.00446.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although the precise underlying pathomechanisms of psoriasis have not been fully elucidated, previous reports suggest that T helper 1-type cytokines are critically involved in the pathogenesis of this disease. Interleukin-12 (IL-12), a heterodimeric cytokine, has been suggested to play a major role in the development of T helper 1 cell responses. In this study, the presence of IL-12 mRNA and protein was investigated in normal human skin as well as nonlesional and lesional psoriatic skin. Messenger RNA levels were determined in biopsy specimens by a standard and a nested reverse transcriptase-polymerase chain reaction method. Additionally, IL-12 protein expression was analyzed in situ by immunohistochemistry using an antibody recognizing IL-12 p70. Whereas specific transcripts for IL-12 p35 were reproducibly detected without any significant differences in all samples, enhanced IL-12 p40 mRNA signals were only found in lesional psoriatic skin as compared with normal and nonlesional psoriatic skin. Furthermore, immunoreactivity for IL-12 p70 was markedly increased in the psoriatic skin lesions and was predominantly expressed on mononuclear cells in the dermis. In conclusion, our data suggest a critical role for IL-12 in promoting and maintaining T cell activation and inducing T helper 1-type cytokines such as interferon-gamma in psoriasis. We speculate that IL-12 might be a key cytokine in the pathogenesis of psoriasis.
引用
收藏
页码:1053 / 1057
页数:5
相关论文
共 32 条
[1]  
Adorini L, 1997, CHEM IMMUNOL, V68, P175
[2]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[3]  
BAKER BS, 1984, BRIT J DERMATOL, V110, P555
[4]  
BARKER JNWN, 1993, AM J PATHOL, V142, P1091
[5]   INTERFERON IN SUCTION BLISTER FLUID FROM PSORIATIC LESIONS [J].
BJERKE, JR ;
LIVDEN, JK ;
DEGRE, M ;
MATRE, R .
BRITISH JOURNAL OF DERMATOLOGY, 1983, 108 (03) :295-299
[6]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752
[7]   The immunopathology of psoriasis [J].
Christophers, E .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 110 (03) :199-206
[8]   PSORIASIS INDUCED AT THE INJECTION SITE OF RECOMBINANT INTERFERON-GAMMA - RESULTS OF IMMUNOHISTOLOGIC INVESTIGATIONS [J].
FIERLBECK, G ;
RASSNER, G ;
MULLER, C .
ARCHIVES OF DERMATOLOGY, 1990, 126 (03) :351-355
[9]   In vivo expression of IL-12 and IL-13 in atopic dermatitis [J].
Hamid, Q ;
Naseer, T ;
Minshall, EW ;
Song, YL ;
Boguniewicz, M ;
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (01) :225-231
[10]   CELL-INTERACTIONS IN PSORIASIS [J].
HENG, MCY ;
KLOSS, SG .
ARCHIVES OF DERMATOLOGY, 1985, 121 (07) :881-887